I treat a variety of blood cancers and benign blood disorders in my role as a hematologic oncologist. At the OSUCCC – James, I’m focused primarily on evaluating and treating plasma cell disorders. I regularly perform autologous stem cell transplants, which involve using a patient’s own healthy blood stem cells to fight their disease. Other procedures I perform include therapeutic plasma exchange, bone marrow aspirate and biopsy, and lumbar puncture for intrathecal chemotherapy. As a clinical assistant professor in the Division of Hematology, I’m excited to help train the next generation of physicians. I’m a member of the Leukemia and Hematologic Malignancies program at the OSUCCC – James. My research is focused on plasma cell disorders, novel treatment options for relapsed/refractory multiple myeloma, and natural outcomes for triple, quad, and penta-refractory disease. I’m also interested in innovative treatments for conditions such as paraproteinemia, amyloidosis, and Waldenstrom macroglobulinemia. My research has been published in peer-reviewed medical journals like the American Journal of Hematology, the Journal of Investigative Medicine, Clinical Lymphoma, Myeloma & Leukemia, and many others. I’ve also been invited to present my research at medical conferences across the United States and the United Kingdom. Additionally, I’m a member of the American Society of Clinical Oncology as well as the American Society of Hematology. I’m glad to be part of the OSUCCC – James team and collaborate with the best cancer specialists in the world. Here at Ohio State, the multidisciplinary approach and access to exceptional resources allows us to provide state-of-the-art, novel diagnostic and treatment options to our patients. It’s a privilege to come to work every day knowing I have the opportunity to significantly advance cancer care and improve patient outcomes.